List of bibliographic references
Number of relevant bibliographic references: 2.
List of associated KwdEn.i
Nombre de documents | Descripteur |
2 | Ankylosing |
2 | Ankylosing spondylitis |
2 | Arthritis rheum |
2 | Asas |
2 | Asas recommendations |
2 | Blocker |
2 | Braun |
2 | Chronic |
2 | Erythrocyte sedimentation rate |
2 | Expert opinion |
2 | Heijde |
2 | Infliximab |
2 | MRI, magnetic resonance imaging |
2 | Magnetic resonance imaging |
2 | Necrosis |
2 | Nsaid |
2 | Rheum |
2 | Rheumatology |
2 | Spondylitis |
2 | TNF, tumour necrosis factor |
2 | Tumour necrosis factor |
1 | AS, ankylosing spondylitis |
1 | ASAS |
1 | ASAS, ASsessment in AS |
1 | ASAS, ASsessment in Ankylosing Spondylitis |
1 | Active ankylosing spondylitis |
1 | Active disease |
1 | Adverse effects |
1 | Andersson lesion |
1 | Antibody infliximab |
1 | Antinuclear antibodies |
1 | Antirheumatic drugs |
1 | Arthritis |
1 | Arthroplasty |
1 | Asas core |
1 | Axial |
1 | Axial disease |
1 | BASDAI, Bath Ankylosing Spondylitis Disease Activity Index |
1 | Basdai |
1 | Basdai criterion |
1 | Basdai score |
1 | Basdai scores |
1 | Bath ankylosing spondylitis |
1 | Bath ankylosing spondylitis disease activity index |
1 | Beneficial effect |
1 | Best evidence |
1 | Biological agents |
1 | Biological treatment |
1 | CI, confidence interval |
1 | Calin |
1 | Cardiovascular |
1 | Cardiovascular events |
1 | Chest expansion |
1 | Clinical experience |
1 | Clinical expertise |
1 | Clinical findings |
1 | Clinical parameters |
1 | Clinical presentation |
1 | Clinical record |
1 | Clinical response |
1 | Clinical trials |
1 | Cochrane database syst |
1 | Comparative studies |
1 | Concomitant |
1 | Concomitant drugs |
1 | Confidence interval |
1 | Congestive heart failure |
1 | Continuous treatment |
1 | Conventional treatments |
1 | Corrective osteotomy |
1 | Corticosteroid |
1 | Corticosteroid injections |
1 | Cost effectiveness |
1 | Coxibs |
1 | Current manifestations |
1 | Current symptoms |
1 | DMARD, disease-modifying antirheumatic drug |
1 | DMARDs, disease modifying antirheumatic drugs |
1 | Demographic characteristics |
1 | Disease activity |
1 | Disease monitoring |
1 | Disease progression |
1 | Dmards |
1 | Dougados |
1 | Drug treatment |
1 | ES, effect size |
1 | EULAR |
1 | Effect size |
1 | Enthesitis |
1 | Etanercept |
1 | Eular |
1 | Eular recommendations |
1 | Evidence hierarchy |
1 | Expert group |
1 | First line drug treatment |
1 | Functional improvement |
1 | Gastroprotective agent |
1 | Gastroprotective agents |
1 | Heart failure |
1 | High disease activity |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/UK/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "J. Sieper"
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i \
-Sk "J. Sieper" \
| HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= UK
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= J. Sieper
}}
| This area was generated with Dilib version V0.6.33. Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 | ![](Common/icons/LogoDilib.gif) |